Ideas Weave Every Narrative with AI.
A master’s graduate built a free, open library that aggregates 35k+ psychedelic research papers from a dozen APIs, deduplicates them, and distinguishes LSD from Lumpy Skin Disease. The real bottleneck in psychedelic science isn’t prohibition—it’s boring infrastructure. This library is a model for turning personal research pain into public good.
A newly identified mushroom doesn’t just cause hallucinations—it triggers a specific, culturally mythic vision of ‘tiny people.’ This discovery reveals that the brain has a hardwired switch for detecting small agents, blurring the line between ancient folklore and modern neuroscience and offering a radical new map for psychedelic therapy and psychosis research.
Anorexia thrives on cognitive rigidity, trapping patients in a devastating feedback loop. Psilocybin isn’t being studied as a magic cure, but as a cognitive crowbar to break that loop. The only reason we’re decades behind on this research is because Nixon banned the drug to target anti-war protesters, not because of science.
The 5-MeO-DMT boom is built on a myth of natural purity. The ‘God molecule’ from the Sonoran Desert toad is identical to the synthetic version, yet seekers pay thousands for a story that is harming an endangered species. The real enlightenment is waking up to the scam.
A single comment — ‘post-burnout, post-psilocin, post-agentic’ — reveals a radical reframe of what burnout actually is. Not a failure to cope, but a deliberate phase of deconstruction. The old identity burns down so something that doesn’t require constant self-optimization can emerge. Recovery isn’t returning to who you were. It’s letting that person stay dead.
A landmark clinical trial proves psilocybin-assisted therapy can treat depression where everything else failed. But the real story isn’t the drug—it’s the paradigm shift from chemical fixes to experiential healing, and why the ‘trip’ might be a side effect, not the cure.